The pipeline of antiviral T‐cell therapy: what's in the clinic and undergoing development
Sign Up to like & getrecommendations! Published in 2019 at "Transfusion"
DOI: 10.1111/trf.15501
Abstract: Virus‐specific T cells allow targeting of multiple pathogens in patients after hematopoietic stem cell transplantation and have demonstrated potential efficacy for cytomegalovirus, Epstein–Barr Virus, and adenovirus. Novel targets may include BK virus, JC virus, varicella… read more here.
Keywords: cell therapy; antiviral cell; pipeline antiviral; cell ... See more keywords
Characterization of antiviral T cell responses during primary and secondary challenge of laboratory cats with feline infectious peritonitis virus (FIPV)
Sign Up to like & getrecommendations! Published in 2019 at "BMC Veterinary Research"
DOI: 10.1186/s12917-019-1909-6
Abstract: BackgroundFeline infectious peritonitis (FIP) is considered highly fatal in its naturally occurring form, although up to 36% of cats resist disease after experimental infection, suggesting that cats in nature may also resist development of FIP… read more here.
Keywords: cell responses; fip; infection; antiviral cell ... See more keywords
Antiviral Cell Products against COVID-19: Learning Lessons from Previous Research in Anti-Infective Cell-Based Agents
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10040868
Abstract: COVID-19 is a real challenge for the protective immunity. Some people do not respond to vaccination by acquiring an appropriate immunological memory. The risk groups for this particular infection such as the elderly and people… read more here.
Keywords: car lymphocytes; cell products; cell; sars cov ... See more keywords